MindImmune Therapeutics Announces
$12.4 million Series A Financing
Investors participating in the round include Dolby Family Ventures, Pfizer Ventures, the Alzheimer’s Drug Discovery Foundation (ADDF), Trend Venture, RightHill Ventures (an affiliate of the Slater Technology Fund) and several private investors.
Providence Business News
Slater Technology Fund
Alzheimer’s Drug Discovery Foundation
Measurement of immune cell recruitment as a biomarker of neuroinflammation in Alzheimer’s disease and other diseases of the central nervous system